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compounds reported in previous literatures. 5 Complex 13 was prepared by using similar methods as described in those works in our group. The 5, 11, 7, 23-Tetraformyl-25, 26, 27, 28-tetrapropoxy-calix [4] arene compound 6 (708 mg, 1 mmol) was dissolved in solution 3.0 mL of anhydrous dichloromethane. 2, 2, 2-trimethoxy-4, 5-dimethyl-1, 3, 2-dioxaphospholene (5 mL) was added and resulting in a yellow clear solution. The similar general pyrazole preparation procedure was followed except for the substitution of hydrazine hydrate (2 ml, 80%) and compound 8 (642 mg, 0.65 mmol) in ethanol (30 mL). 5 And then the solution was cooled and concentrated under vacuum, the resulting crude residue was recrystallized from DMSO/CH 3 OH affording compound 1 as a white power (Yield: 546 mg, 85% 
S2. X-ray crystallography of compound 1
X-ray diffraction data of the crystals of compound 1 was collected by using synchrotron radiation ( = 0.80010 Å)
in the experiment room 3W1A with the approval of BSRF. The diffraction date reduction and integration were performed by HKL2000 software. Positions of the Pd atoms and most of the non-hydrogen atoms were found by using the direct methods program in the Bruker SHELXTL software package. All Hydrogen atoms were placed in calculated positions in the final structure refinement. In compound 1, the unit cell includes a large region of disordered solvent molecules, which could not be modeled as discrete atomic sites. We employed PLATON/SQUEEZE to calculate the di raction contribution of the solvent molecules. 
